Previous close | 21.70 |
Open | 21.70 |
Bid | 19.20 |
Ask | 19.70 |
Strike | 240.00 |
Expiry date | 2025-01-17 |
Day's range | 21.70 - 21.70 |
Contract range | N/A |
Volume | |
Open interest | 202 |
ALGN is facing a decline in Invisalign ASPs for comprehensive treatment options. This is resulting in a decline in the company's revenues.
TEMPE, Ariz., September 04, 2024--Align Technology, Inc. ("Align") (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at an upcoming financial conference. The presentation, as noted below, will be webcast live via the Investor Relations section of Align
TEMPE, Ariz., September 03, 2024--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced leadership updates for the Asia Pacific, Americas, and EMEA regions. Medical technology industry executive David Carr has joined Align as EVP and MD of the Asia Pacific region. Raj Pu